HF-OCT (Vascular Imaging System)

History

2024: System Release

At the end of October 2024, the American company Gentuity introduced the HF-OCT imaging system with the Vis-Rx microcatheter, which is used both before and after percutaneous coronary intervention (PCI). According to the developers, it is the only intravascular imaging platform in the world specifically designed to assess the condition of coronary vessels before and after intervention.

Recent studies have shown that visualization of the vascular bed before PCI using optical coherence tomography led to a change in intervention strategy in 80% of cases. Based on the data obtained, surgeons changed the assessment of the degree of damage (45%), the vascular preparation strategy (27%), the diameter of the stent (37%) and the length of the stent (36%).

𝓲

gentuity.com

Based on this data, Gentuity has developed and marketed its Vis-Rx microimaging catheter. The company claims to be the world's smallest coronary vascular imaging platform with a diameter of just 1.8 F. This allows for the necessary preoperative vascular imaging without prior coronary artery dilation. The system also optimizes the course of the PCI procedure and improves the accuracy of the intervention, allowing doctors to assess coronary arteries in their natural state. In addition, the developers offer special analytical tools based on artificial intelligence, which allow you to quickly evaluate the results obtained.

Regulatory approval to sell our device marks an important milestone in the deployment of the Gentuity HF-OCT system, "noted Desmond Adler, President of Gentuity. - Doctors will now be able to assess vascular conditions before PCI without prior dilation, opening up unmatched opportunities for surgeons to optimize treatment plans.[1]

Notes